EZZ Life Science Holdings Limited (ASX:EZZ)
Australia
· Delayed Price · Currency is AUD 1.045
+0.015 (1.46%)
Mar 10, 2026, 11:52 AM AEST
EZZ Life Science Holdings Revenue
EZZ Life Science Holdings had revenue of 36.59M AUD in the half year ending June 30, 2025, with 66.17% growth. This brings the company's revenue in the last twelve months to 61.40M, down -18.17% year-over-year. In the fiscal year ending June 30, 2025, EZZ Life Science Holdings had annual revenue of 66.87M with 0.65% growth.
Revenue (ttm)
61.40M
Revenue Growth
-18.17%
P/S Ratio
0.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
48.48M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Entropy Neurodynamics | 1.58M |
| Proteomics International Laboratories | 3.21M |
| Amplia Therapeutics | 5.01M |
| Neurizon Therapeutics | 5.98M |
| Prescient Therapeutics | 4.27M |
| Avecho Biotechnology | 1.24M |
| Imugene | 3.94M |
| Radiopharm Theranostics | 16.28M |